Warby Parker Inc.
HealthcareNYSE:WRBY · New York Stock Exchange
+$0.60 today
Vol 1.98M · Avg 2.81M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
0.4%
avg -19.1%
ROIC
-0.5%
avg -15.1%
ROA
0.2%
avg -11.2%
Analysis
ROE is currently the strongest return metric at 0.4% versus its period average of -19.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Neil Harris Blumenthal | Co-Founder, President, Co-CEO & Co-Chair | $591,500.00 | — | 45 | $3.00M | 2.45% |
David Abraham Gilboa | Co-Founder, Co-CEO & Co-Chair | $589,000.00 | — | 44 | $60,109.00 | 0.05% |
Andrew Hunt | Co-Founder & Independent Director | $75,000.00 | — | — | $1.94M | 1.58% |
Jeff Raider | Co-Founder & Independent Director | $75,000.00 | — | — | $457,701.00 | 0.37% |
Jaclyn Berkley | Head of Investor Relations | — | — | — | — | — |
Chris Utecht | Senior Vice President, General Counsel & Secretary | — | — | — | — | — |
Jeffrey Saunders | Senior Vice President & Chief Technology Officer | — | — | — | $457,701.00 | 0.37% |
Chelsea Kaden | Senior Vice President & Chief People Officer | — | — | — | — | — |
Lori Krauss | Senior Vice President & Chief Marketing Officer | — | — | — | — | — |
Sandy Gilsenan | SVP and Chief Retail & Customer Experience Officer | — | — | — | — | — |
Adrian V. Mitchell | CFO & Principal Accounting Officer | — | — | 52 | $0.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
39
$43.69M
Net Sentiment
$43.69M
Net selling
Most Active
Blumenthal Neil Harris
16 transactions
1–10 of 39
Analysis
Insiders reported 0 buys worth $0.00 and 39 sells worth $43.69M over the last 12 months. That adds up to net selling of $43.69M. Blumenthal Neil Harris was the most active insider with 16 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | +19.4% | +18.4% (5yr)4 analysts |
| Net Income | N/A | N/A | N/A | N/A4 analysts |
| EBIT | N/A | N/A | N/A | N/A4 analysts |
Analysis
Recent growth has been strongest in Revenue at +19.4% over three years. Forward estimates point to Revenue at +18.4% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Concentra Group Holdings Parent, Inc.
NYSE:CON
$3.60B
ICU Medical, Inc.
NASDAQ:ICUI
$3.55B
Haemonetics Corporation
NYSE:HAE
$3.55B
Integer Holdings Corporation
NYSE:ITGR
$3.09B
Beam Therapeutics Inc.
NASDAQ:BEAM
$2.99B
Premier, Inc.
PINC
$2.34B
LeMaitre Vascular, Inc.
NASDAQ:LMAT
$2.10B
DENTSPLY SIRONA Inc.
NASDAQ:XRAY
$2.02B
Bausch Health Companies Inc.
NYSE:BHC
$1.89B
QuidelOrtho Corporation
NASDAQ:QDEL
$963.54M
Who manages WRBY?
Warby Parker Inc. (WRBY) lists 11 active executives. The top listed executive is Jaclyn Berkley, Head of Investor Relations.
Are WRBY insiders buying or selling?
Recent insider activity shows net selling of $47.27M.
Explore More
Continue the stock analysis
Jump to another research area for this company.